The related cytokines, interleukin-6 (IL-6), oncostatin M (OSM), and leukemia inhibitory factor (LIF) direct the formation of specific heteromeric receptor complexes to achieve signaling. Each complex includes the common signal-transducing subunit gp130. OSM and LIF also recruit the signaling competent, but structurally distinct OSMR␤ and LIFR␣ subunits, respectively. To test the hypothesis that the particularly prominent cell regulation by OSM is due to signals contributed by OSMR␤, we introduced stable expression of human or mouse OSMR␤ in rat hepatoma cells which have endogenous receptors for IL-6 and LIF, but not OSM. Both mouse and human OSM engaged gp130 with their respective OSMR␤ subunits, but only human OSM also acted through LIFR. Signaling by OSMR␤-containing receptors was characterized by highest activation of STAT5 and ERK, recruitment of the insulin receptor substrate and Jun-N-terminal kinase pathways, and induction of a characteristic pattern of acute phase proteins. Since LIF together with LIFR␣ appear to form a more stable complex with gp130 than OSM with gp130 and OSMR␤, co-activation of LIFR and OSMR resulted in a predominant LIF-like response. These results suggest that signaling by IL-6 cytokines is not identical, and that a hierarchical order of cytokine receptor action exists in which LIFR ranks as dominant member.
and controlling homostatic processes. These roles were identified by the effects of transgenic cytokine expression, the knockout of cytokine genes in mice (2) (3) (4) (5) , or by in vivo treatments with pharmacological doses of cytokines or activity neutralizing antibodies (6 -11) . OSM is produced by activated monocytes and lymphocytes (12, 13 ) (e.g. at sites of inflammation) and acts locally on stromal cells. Stromal cells in turn respond prominently by enhanced production of IL-6 and LIF (14) . IL-6 and LIF enter into circulation and participate in the recruitment of the systemic inflammatory response that includes the acute phase reaction of the liver (1, 15) .
Each of the IL-6 cytokines is recognized by a specific ligand binding subunit, i.e. IL-6 by IL-6 receptor ␣ (IL-6R␣), LIF by LIFR␣ (note, this subunit has also been called LIFR␤; Ref. 16) , and OSM (human) by gp130. These cytokine receptor complexes cooperate with a second, signal-transducing subunit to form a signaling-competent receptor unit (abbreviated as follows: IL-6R consisting of IL-6R␣-gp130; LIFR consisting of LIFR␣-gp130; and OSMR (also defined as type II OSMR) consisting of gp130-OSMR␤ (17, 18) ). In human cells, hOSM also engages a type I OSMR consisting of gp130-LIFR␣ that is equivalent to LIFR (19) . Ligand-induced receptor subunit interaction results in trans-and autophosphorylation of Janus protein tyrosine kinases (JAKs) that are associated with the cytoplasmic domains of the receptor subunits. Tyrosine phosphorylation of the receptor subunits, including gp130, creates docking sites for signal-communicating STAT3 and linker proteins which, upon their phosphorylation, propagate the signal to other pathways (MAPK and phosphatidylinositol 3-kinase) (reviewed in Refs. 17, 18, 20, and 21) . The combined effects of the receptor-dependent processes and the complement of existing transcription factors determine the mode of gene regulation that, in the case of hepatocytes treated with IL-6 cytokines, results in enhanced transcription of genes encoding type 2 APP, including: fibrinogen, haptoglobin (HP), and thiostatin (TST), and ␣ 2 -macroglobulin (␣ 2 -MG) (15, 22) .
The patterns of APP gene expression in rodent and human hepatic cells suggest that quantitative differences in regulatory activity exist among IL-6 family members, where OSM shows the strongest activity (23) (24) (25) (26) . These differences in cell responses have been interpreted to be caused by differences in receptor levels, ligand interaction with subunits, or the ability of heteromeric or homomeric complexes of the three signaling subunits (gp130, LIFR␣, and OSMR␤) to engage subunit-specific signal-communicating pathways (16, 17, (27) (28) (29) (30) . Based on structural and functional analyses of receptor subunits in transfected cells (27, 29) , we hypothesize that the different receptor subunits contribute specific signaling reactions that define the cell responses to the different IL-6 cytokines. Hence, we predict that the OSMR␤ subunits are particularly effective in signal transduction, accounting for the high level of OSM effects. It has not previously been possible to precisely compare the regulatory action of the key IL-6 cytokine receptors, IL6R, OSMR, and LIFR, and to specifically define the cell response as a function of OSMR␤ expression since appropriate cell lines were not available. However, several properties of the recently cloned mouse OSMR␤ (31, 32) now make it possible to define OSMR-specific action. The amino acid sequence of mOSMR␤ shows 55% identity to the hOSMR␤ sequence. Furthermore, mOSMR␤ appears to form a type II OSMR complex only with rodent OSM (31) (32) (33) . This differs from the type I and II OSMR engaged by hOSM in human cells. To assess the function of OSMR␤-dependent receptor systems and distinguish between the activity of type I and II OSMR, we reconstituted OSMR in a clonal line of rat H-35 hepatoma (22) . These cells have active IL-6R, IL-11R, and LIFR systems, but are deficient in the expression of OSMR␤. The present studies demonstrate that 1) OSMR␤ subunit assists in recruitment of a broader spectrum of signaling pathways than achieved by gp130 activation alone, 2) the particularly prominent activation of STAT5 and ERK pathways by OSMR accounts in part for the OSM specific gene regulatory pattern, and 3) the OSM response is influenced by coactivation of the LIFR.
MATERIALS AND METHODS
Tissue Culture Cells-Human HepG2 (clone 86-6; Ref. 34) , rat H-35 (clone T-7-18; Ref. 22) , and H-35 cells stably expressing G-CSFR-gp130 (35) , were cultured in Dulbecco's modified Eagle's medium containing 10% fetal calf serum and antibiotics. Cells used for analyzing signaling were maintained for 18 -24 h in serum-free Dulbecco's modified Eagle's medium. Treatments were carried out in serum-free medium containing cytokines at concentrations ranging from 0.01 to 1000 ng/ml (standard treatments used 100 ng/ml) of recombinant human IL-6 and LIF (Genetics Institute), human granulocyte-colony stimulating factor (G-CSF), hOSM (Immunex Corp), mOSM (prepared in COS-1 cells as described in Ref. 32) , or 1 M dexamethasone (Sigma). MEK-1 activity was inhibited by 5-25 M U0126 (Promega, Madison, WI).
Plasmid Constructs-The cDNA to mOSMR␤ in pME18S (32) and hOSMR in pDC409 (33) were modified by the addition of FLAG epitope (DYKDDDK) to the C terminus. The OSMR␤-FLAG constructs were transferred as NotI fragments into the retroviral vector MINV (36) and the vector-derived viruses were used to transduce H-35 cells (35, 37) . Two days after viral infection, the transduced cells were selected in medium containing 2 mg of G418/ml. From the primary cultures of transduced cells (which normally contain 100 to 10000 separate clones), 24 to 48 clones were picked, expanded, and subcloned. Subclonal lines were characterized for relative expression of OSMR␤ by FLAG immunoblotting, ligand-induced receptor tyrosine phosphorylation, and induction of APPs. The remaining cells on the primary culture plates were maintained and classified as a pool of stably transduced H-35 cells (termed hOSMR␤-H-35 cell or mOSMR␤-H-35 cells). The following expression vectors have been described previously: human LIFR␣ with deleted cytoplasmic domain (LIFR␣⌬cyto) in pDC302 (27) , rat STAT5B and STAT5B⌬4OC (lacking 41 residue of C-terminal transactivation domain) in pSV-Sport 1 (38) , and the reporter-CAT gene constructs containing the indicated APP promoters, p␣ 2 -MG (2700)-CAT (39), pHP (4200)-CAT (40) , and pTST(1516)-CAT (41) and the STAT3-and STAT5-sensitive construct p(8XHRRE)-CAT (42) .
Transient Transfection-HepG2 cells were transfected by the calcium-phosphate method (43) with a total of 20 g of DNA/ml, including 0.25 g of pEGFP(N1) (Upstate Biotechnology Inc.) as internal transfection marker, 15 g of CAT-reporter construct, 0.5-2 g/ml expression vector for receptor, and the balance with empty vector. H-35 cell lines were transfected with FuGene6 (Roche Molecular Biochemicals) according to the manufacturer's recommendation using a ratio of 6 l of FuGene6 to 4 g of DNA. Cell cultures were subdivided immediately after transfection, and 24 h later these cultures were treated for 24 h with serum-free medium containing the inducing factors. To inhibit gp130 function in HepG2 cells during cytokine treatment, the cells were maintained in the presence of activity neutralyzing monoclonal antibodies against human gp130 ("144," Ref. 44 ). Prior to cell extraction, expression of green fluorescent protein (GFP) was visualized under a Nikon inverted fluorescence microscope. A digitized image of GFP positive culture at ϫ 40 magnification was taken by a SPOT camera (Diagnostic Instruments, Inc.) and GFP fluorescence signal above background quantitated in the NIH Image program version 1.62. The integrated net pixel values relative to a constant view area were used as a measure for transfection efficiency. CAT activity in serially diluted cell extract was determined, normalized to the GFP signal for each culture, and expressed in relative CAT activity. To obtain enriched cultures of H-35 cells transfected with expression vectors for STAT5 isoforms, 24 h after transfection, GFP negative (served as controls) and GFP positive cells were selected by sterile fluorescence-activated cell sorting as described (45) . This approach yielded 0.5 to 1 ϫ 10 6 GFP positive cells representing a 50% recovery of the original 5% transfected cells in the culture. The cells were plated into 24-well culture plates (2.5 ϫ 10 5 cells per well). Following 24 h recovery, the cells were treated for an additional 24 h with cytokines in the presence of dexamethasone. Conditioned medium was used to measure the amounts of plasma proteins. Cell extracts were analyzed by Western blotting for the expression of STAT5 proteins.
Immunoprecipitation and Western Blotting-Cell monolayers were washed twice with ice-cold phosphate-buffered saline and lysed in RIPA buffer (0.5 ml/10-cm 2 cell monolayers). Lysate containing ϳ2 mg of protein were diluted to 1 ml of RIPA buffer, precleared, and incubated for 2 h with specific antibodies to gp130, LIFR, SHC (Santa Cruz Biotechnology), SHP-2 (Up-State Biotechnology Inc.), FLAG (M 2 antibody; Eastman Kodak Co.), phosphotyrosine (Py20; Transduction Laboratories, combined with 4G10; Upstate Biotechnology, Inc.), extracellular domain of hOSMR (Immunex; Ref. 46 ) for 2 h at 4°C. Immunocomplexes were recovered by incubation with 50 l (50% slurry in RIPA buffer) of protein G-conjugated Sepharose (Amersham Pharmacia Biotech) for 1 h at 4°C with agitation. Beads were washed three times with RIPA buffer and boiled in SDS sample loading buffer. The immunoprecipitates or aliquots of whole cell lysates were separated on a 6 -10% SDS-polyacrylamide gel and proteins transferred to protean membranes (Schleicher & Schuell). Wherever possible, separation of replicate sample aliquots was preferred over sequential probing of the same membranes in order to circumvent antigen loss. Where separate antigens of different sizes were analyzed, the membrane was cut into horizontal sections containing the specific size categories of antigens. The membranes were reacted with primary antibodies and secondary antibodies (horseradish peroxidase-conjugated anti-mouse or anti-rabbit antibodies (Cappel, West Chester, PA) in TBST (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Tween 20) containing 5% milk or 3% albumin. Results were visualized by enhanced chemiluminescence reaction (ECL) according to the manufacturer's directions (Amersham Pharmacia Biotech). To perform additional immunoreactions, membranes were treated for 30 min with 62.5 mM Tris-HCl, pH 6.8, 2% SDS, and 100 mM 2-mercaptoethanol.
Northern Blot Hybridization-Total cellular RNA was extracted by the Trizol method (Life Technology, Grand Island, NY). Aliquots of 5-20 g were separated on 1.5% formaldehyde-agarose gel, transferred onto nylon membrane (Schleicher & Schuell), and reacted with 32 Plabeled cDNA probes for rat ␣ 2 -MG, HP, or TST. Ethidium bromide staining pattern of separated RNA was used as a marker for sample loading.
Plasma Protein Analysis-Synthesis and secretion of APP into the culture medium of cytokine-treated H-35 cells were quantitated by immunoelectrophoresis, using equal aliquots of cell-free conditioned medium (47) . The area under the precipitation peaks (proportional to amount of antigen) was integrated, using the NIH image program and expressed in arbitrary immunoelectrophoretic units normalized to the amount of cell protein.
Thymidine Incorporation-H-35 cells were subcultured in 96-well plates (2.5 ϫ 10 4 cells/well). After 24 h, the cells were treated first for 8 h with serum-free medium, then switched to fresh serum-free medium with or without cytokines (8 wells per treatment). Following 16 h incubation, 0.4 Ci of [ 3 H]thymidine was added to each well and incubation continued for an additional 8 h. The cells were washed, released by trypsin, and collected onto filter paper with a cell harvester. Incorporation of 3 H was measured by scintillation counting (Wallac, Gaithersburg, MD). Statistical evaluation of the data was performed by Student's t test.
RESULTS
Mouse mOSMR␤ Signals Through Human gp130 -To assess whether the cloned mOSMR␤ formed a signaling-competent complex with gp130 and whether this complex is functional, the expression vector for mOSMR␤, together with the OSM-responsive HRRE-CAT reporter gene construct, was transiently transfected into HepG2 cells (Fig. 1 ). HepG2 cells have an endogenous OSMR system, comprised of type I and II OSMR, that effectively mediated a prominent CAT gene induction in response to human, but not mOSM (Fig. 1, left panel) . Expression of transfected mOSMR␤ by itself did not detectably modify the activity of the other IL-6 cytokine receptors, but introduced an mOSM-specific gene induction comparable to the endogenous hOSMR (Fig. 1, second panel) . That mOSM did not promote interaction with LIFR␣ was confirmed by overexpression of a membrane form of hLIFR␣ that lacks the cytoplasmic domain (LIFR␣⌬cyto). This form acted as a competitive inhibitor of both full-length LIFR␣ and hOSMR␤ of HepG2 cells by generating an hOSM-dependent, but signaling-incompetent complexes with gp130. LIFR␣⌬cyto eliminated the cell response to hOSM but did not affect mOSM action (Fig. 1, third  panel) . However, a functional, ligand-dependent cooperation of transfected mOSMR␤ with the endogenous gp130 was identified by its inhibition with anti-gp130 antibodies (Fig. 1, right  panel) . These results established functionality of the mOSMR␤ construct and indicated that human gp130 was capable of cooperating similarly with mouse and human OSM and OSMR␤ in forming a signal-transducing complex.
OSMR␤ Introduces a Type II OSMR Activity in H-35 Cells-To characterize the regulatory activity of OSMR on endogenous genes as function of OSMR␤ expression, we employed H-35 cells. These cells showed an approximately equal expression of gp130 and LIFR␣ and responded to IL-6 or LIF by a similar level of tyrosine phosphorylation of gp130 (Fig. 2) . As described below, the cytokine treatment also resulted in a comparable activation of STAT3 (Fig. 4A ) and induction of type 2 APPs (Fig. 7B) . In H-35 cells, expression of OSMR␤ mRNA was undetectable by hybridization analysis (data not shown) and mOSM treatment did not produce an appreciable regulatory effect. The LIF-like response to hOSM treatment had been attributed to the hOSM-mediated engagement of LIFR␣ into a type I OSMR complex, an activity not exerted by mOSM ( Fig. 2A ). An unexpected finding, and convenient tool for subsequent functional analysis of receptor subunit-associated proteins, was that under the conditions selected for immunoprecipitation, the hOSM-directed interaction of LIFR␣ and gp130 was less stable than that directed by LIF. This is demonstrated by the absence of gp130 from the LIFR␣-containing complex immunoprecipitated from hOSM-treated cells ( Fig. 2A) . Identical immunoprecipitation of the LIF-induced complex yielded equal immunoblot signals for the tyrosine-phosphorylated LIFR␣ and gp130 subunits.
Based on the data from HepG2 cell transfection ( Fig. 1) , it is expected that expression of human or mouse OSMR␤ would introduce in H-35 cells, an OSM-directed gene regulatory activity that is similar to, or exceeds that of IL-6. Additionally, the expression of hOSMR␤ should introduce type II OSMR signaling in parallel to hOSM-coordinated endogenous type I OSMR. Stable expression of human and mouse OSMR␤ was established in H-35 cells by retroviral transduction. Initial experiments verified that native OSMR␤, and OSMR␤ carrying a C-terminal FLAG epitope, were equivalently active in signal communication. Hence, to facilitate structure/functional analyses of the OSMR␤-containing complexes, most studies were carried out with cells expressing the FLAG-modified receptor proteins.
Several independently generated pools of H-35 cells stably transduced with hOSMR␤ or mOSMR␤ consistently showed a single form of anti-FLAG reactive OSMR␤ protein with the predicted molecular mass of 160 to 180 kDa (Fig. 2B ,
Signaling by mOSMR␤ in combination with human gp130. HepG2 cells were transfected with p8XHRRE-CAT (15 g/ml) alone or together with expression vector for mOSMR␤ (0.5 g/ml) with or without addition of the expression vector for human LIFR␣⌬cyto (2 g/ml). Subcultures were treated with the cytokines (100 ng/ml) and anti-gp130 antibodies (10 g/ml) for 24 h as indicated. CAT activities were determined (lower panel) and expressed relative to the untreated control (upper panel). Refs. 31-33 and 48). Northern blot (not shown) and immunoblot analyses indicated that in each receptor-transduced culture, the relative expression of mRNA and proteins was closely correlated. The comparison of hybridization signals on Northern blots also indicated that the average level of mOSMR␤ mRNA was in the range of that of NIH 3T3 cells, and the level of hOSMR␤ mRNA and protein was similar to that of HepG2 cells.
Due to technical limitations of the binding assay for OSM (29, 33), we could not obtain a convincing quantification of OSMR␤-dependent, high affinity binding sites for human or mouse OSM introduced by transduction in H-35 cells. Therefore, the cell surface-assessable and functionally relevant OSMR␤ proteins were determined by ligand-dependent tyrosine phosphorylation of the subunit proteins (33, 48) . LIFinduced modification of endogenous LIFR␣ and gp130 served as internal references (Fig. 2B) . Treatment of the cells for 15 min with OSM initiated tyrosine phosphorylation of the receptor subunits in the range of that observed for endogenous LIFR (Fig. 2B ) and gp130 (Fig. 3A, right panel) . The cells showed a strictly species-restricted recruitment of OSMR␤ subunit by OSM (Fig. 2B) . The same analysis also confirmed that hOSM, but not mOSM, engaged endogenous LIFR␣ in forming a signaling competent type I OSMR (Fig. 3A, right panel) . Surprisingly, when using conditions for co-immunoprecipitation that recovered the LIF-stabilized complex of LIFR␣ and gp130, no significant co-immunoprecipitation of gp130 with hOSMR␤ (Fig. 3A, left panel) , and only a very minor amount of gp130 with mOSMR␤ (Fig. 3B) , was observed. Similarly, an antibody that recognized an epitope in the extracellular, hematopoietic domain of hOSMR (33) , rather than the C-terminal FLAG epitope, failed to co-immunoprecipitate gp130 as part of the ligand-activated complex (Fig. 3A, left panel) . These results suggested that human and mouse OSM mediated a weaker interaction of receptor subunits than LIF, and that our immunoprecipitation conditions were sufficiently stringent to distinguish between LIF and OSM coordinated receptor complexes.
The Immediate Signaling Reactions by OSMR Differ from IL-6R and LIFR-The gain of specific signaling activity as a function of transduced OSMR␤ was taken as evidence for the functional contribution by this receptor subunit (Fig. 4) . The comparison of OSMR␤-dependent signaling, mediated by the resident IL-6R and LIFR, allowed for assessment of the signaling specificity. In all transduced H-35 cell cultures, the relative activity of the IL-6 and LIF signals were essentially identical to those established in parental cells (Fig. 4A) . Similarly, the hOSM effects in mOSMR␤-transduced cells (Fig. 4B ) were indistinguishable from hOSM effects in parental cells. As expected from the comparable level of receptor protein phosphorylation (Fig. 3) , IL-6, mOSM, hOSM, and LIF were similarly effective in activating STAT3 (Fig. 4B) . Stimulation reached maximal level after 5 min treatment, slowly declined to a nadir at ϳ60 min, and rose minimally by 120 min. Specific to OSMR␤-mediated response was the prominent activation of STAT5 and ERK, both with a peak level at 15 min, and thus delayed relative to STAT3. The differential kinetics of signaling toward STAT3 and was also identified by the analyses of cytoplasmic and nuclear fractions of cytokine-treated cells (data not shown), confirming the sequential activation and nuclear translocation of tyrosine-phosphorylated STAT3 and STAT5.
LIF, and hOSM through the type I OSMR complex, activated STAT5 and ERK stronger than IL-6, but less than OSM through type II OSMR. No appreciable reaction to mOSM treatment was detected in hOSMR␤-expressing cells (data not shown), indicating that hOSMR␤ could not serve as a functional partner in a complex with mOSM and rat gp130. Treatment of hOSMR␤ cells with hOSM produced a signaling response (Fig. 4C ) that clearly exceeded that elicited by LIF. Of note was that in independently derived H-35 cultures expressing hOSMR␤, a temporarily prolonged activation of ERK was detected at 30 min and at later time points, exceeded the effects of mOSM in mOSMR␤ expressing cells. This finding suggested that at this level of signaling action of type I and II OSMR was additive. Serial dilution of the cytokines established that maximal cell response was attained at approximately 10 ng/ml (Fig. 4D) .
Intracellular Signaling by mOSMR Involves Additional Pathways-To define the type II OSMR-specific signaling reactions independent of type I OSMR signaling, we focused on the analysis of mOSMR ␤-transduced H-35 cells in the following experiments. Since continuous culturing of the heterogeneous populations of transduced H-35 cells invariably led to phenotypic drifting of the cultures, a clonal line was used to further characterize mOSMR-specific action. From a panel of 24 primary clones, which displayed severalfold difference in receptor protein expression and signal activity, we selected one line (27-7) that expressed mOSMR␤ mRNA and FLAG-tagged sub- were treated for 15 min as indicated at the bottom, and then lysed. Equal amounts of cell extract were subjected to immunoprecipitation (I.P.) using antibodies to the receptor subunits as indicated above or left of the blots. Recovered proteins were analyzed by immunoblotting as indicated. Note that treatment with hOSM, but not mOSM, yields an activation of LIFR␣. However, this subunit activated by OSM does not appreciably co-immunoprecipitate gp130, despite the high level of tyrosine phosphorylated of the latter. In B, the electrophoretic separation of the proteins of the Ͼ100 kDa range was extended. The positions of the receptor subunit proteins and molecular size markers are marked. unit protein at the average level of the initial pool of transduced cells.
The signal events that were initiated by the OSMR subunits and then extended to associated proteins were assessed by the time course of protein phosphorylation (Fig. 5) . The major changes detectable by anti-phosphotyrosine in cell lysate included proteins co-migrating with mOSMR␤ and gp130 (Fig. 5A) . The anti-FLAG-reactive proteins demonstrated that mOSMR␤ underwent a ligand-induced, 2-3-fold reduction within 30 min to 2 h of treatment. At 30 min following treatment, a transient appearance of two anti-FLAG reactive proteins at ϳ45 kDa position was noted. These smaller proteins have been tentatively identified as intermediate, membraneassociated breakdown products of mOSMR␤, resulting from proteolytic release of the extracellular domain within the endocytic compartment. Since no appreciable changes in mRNAs for mOSMR␤ could be detected in OSM-treated cells (data not shown), a modification of receptor levels by a post-transcriptional process such as enhanced turnover was suggested.
The clonal cell line reproduced the two distinct kinetic profiles of mOSM-dependent signaling reactions (Fig. 5B) . Tyrosine phosphorylation of mOSMR␤, gp130, JAK1, SHC, ERK, and STAT5 was temporally coordinated and was maximal at 15 min. Tyrosine phosphorylation of SHP-2 and STAT3 displayed peak values after a 5-min treatment. The faster time course of signaling was comparable to that observed for the signaling in response to IL-6 and LIF (Fig. 4, A and B; Refs. 37 and 49) . The mOSMR␤-expressing cells also exhibited a mOSM-dependent activation of JNK (Fig. 5B) but not p38 MAPK. The engagement of the stress MAPK pathway by mOSMR signal (but not observed with IL-6 or LIF treatments) was, however, only a fraction of that achieved by IL-1␤ in the same cells (not shown).
The recruitment of insulin receptor substrate (IRS) proteins represented an additional signaling pathway activated by mOSMR (Fig. 5B) and to a lesser extent by LIFR, but not detectably by IL-6 (data not shown; Refs. 50 and 51). In H-35 cells, IRS-2 was primarily phosphorylated in response to mOSM and was found in association with phosphatidylinositol 3-kinase (Fig. 5B, bottom) . Although activation of the IRS/ phosphatidylinositol 3-kinase pathway by mOSM was not as effective as by insulin (52), together with the prominent activation of STATs (a process not appreciably mediated by insulin), it produced a signal combination highly characteristic for mOSMR.
Recruitment of SHC Is Specific to OSMR␤-Recently, we showed that in hepatoma cells, the dimeric gp130 engages the ERK pathway through a mediator role of SHP-2 (49). In mOSMR␤-expressing H-35 cells, mOSM treatment also led to tyrosine phosphorylation of SHP-2 (Fig. 5B) . Since the cytoplasmic domain of mOSMR␤, in contrast to that of gp130, does not contain a docking motif for SHP-2, the recruitment of SHP-2 by OSM treatment had been tentatively attributed to gp130 within the type II OSMR complex. The kinetics by which SHP-2 and the downstream ERK were phosphorylated differed significantly from each other (Fig. 5B) , suggesting a separate link from mOSMR␤ to the MAPK pathways that acted in 
showing optimal quantitative signal differences among the samples (avoiding overexposure of most reactive bands) were used to generate the composite picture. In D, the blots for phosphorylated ERK were exposed longer to ECL reaction for demonstrating ERK activation.
addition that controlled by gp130. SHC appeared as a possible candidate because it was also enhanced phosphorylated following OSM treatment (Fig. 5B) . A similar phosphorylation of SHC by the action of hOSMR␤ was also observed in hOSMR␤-transduced H-35 cells and in OSM-treated HepG2 cells (data not shown).
Immunoprecipitation of SHP-2 was effective in recovering ligand-activated (tyrosine-phosphorylated) gp130, as well as the tightly interacting LIFR␣-gp130 complex, but not of mOSMR␤ (Fig. 6A, left panel) . In contrast, immunoprecipitation of SHC specifically yielded the activated mOSMR␤ (Fig.  6A, right panel) . A comparable interaction of SHC with activated human and mouse OSMR␤ was detected (Fig. 6B) . The receptor subunit-specific recruitment of SHC and SHP-2 was interpreted as a potential explanation for the prominent ERK, and conceivably also of the JNK pathway by OSMR. Additional downstream effects of OSMR signaling were recognized by the presence of strongly tyrosine-phosphorylated proteins that coimmunoprecipitated with SHP-2 and SHC (Fig. 6A, open arrows) . These proteins exhibited apparent molecular sizes of 120 kDa and may include Gab-1 and the major forms of SIRPs (53, 54) .
OSMR Signals Have Specific Effects on Proliferation and APP Gene
Expression-Events downstream of OSMR signaling have been described for different cell types, including enhanced or suppressed proliferation, induced apoptosis, or enhanced gene transcription. Hepatoma cells, like primary cultures of rodent hepatocytes, did not show any detectable apoptotic reactions, when treated with any of the IL-6 cytokines at doses as high as 1 g/ml (data not shown). However, H-35 cells responded to IL-6 cytokines, in particular mOSMR␤-expressing H-35 cells to mOSM, by suppressed proliferation as demonstrated by reduced [ 3 H]thymidine incorporation (Fig. 7A ) and lower cell counts after 3 days of treatment (data not shown). Flow cytometric analysis indicated a proportionally increased fraction of the cells in G 1 phase. 2 Simultaneously with growth inhibition IL-6 cytokines induced and supported elevated APP expression. The relative effects of mOSM, hOSM, IL-6, and LIF on expression of the representative APPs, TST, HP, and ␣ 2 -MG, were determined by immunoblotting (Fig. 7B ) and immunoelectrophoresis Fig. 7C ) of the secreted proteins, and by RNA hybridization (e.g. Fig. 8A ; below). Characteristic patterns of regulation by the individual cytokines, alone or in combination with dexamethasone, emerged that could be confirmed in independently derived pools as well as in clonal lines of transduced cells.
In the presence of dexamethasone (required for expression of ␣ 2 -MG), mOSM proved to be the most effective inducer of ␣ 2 -MG (Fig. 7C) . At the maximal dose of OSM tested, the expression of ␣ 2 -MG was 2-fold higher than that induced by IL-6. mOSM induced TST at a level close to that of IL-6, but was least effective on HP (Fig. 7, B and C) . Notable was that TST and HP regulation by OSM, in contrast to IL-6, did not demonstrate a strong synergism with dexamethasone (Fig. 7B) . By utilizing maximal magnitudes of induction as defining criteria, the comparison indicated the following preference of the cytokines to regulate APP: mOSM (or hOSM through type II OSMR) ␣ 2 -MG Ͼ TST Ͼ HP; IL-6: TST Ͼ ␣ 2 -MG Ͼ HP; and LIF (or hOSM through type I OSMR): HP ϾTST Ͼ ␣ 2 -MG. The relative activities of the cytokines on APP gene expression were maintained for at least 96 h of treatment (not shown).
Cytokine dose-response analysis (Fig. 7 , B and C) uncovered a second important difference among the cytokines. Mouse or human OSM, acting through type I or II OSMR, and IL-6 produced a similarly sharp decline in APP inducing activity in the range of 10 to 1 ng/ml (35, 49) . In contrast, LIF displayed a sustained induction profile with half-maximal stimulation at ϳ0.1 ng/ml. This distinct dose-response of LIF relative to IL-6 had been reported before for the induction of fibrinogen in H-35 and HepG2 cells (23, 24, 26) but had been left unexplained. The fact that hOSM through the same LIFR-gp130 (type I OSMR) complex was not reproducing a LIF-like regulatory pattern suggested a ligand-dependent signal control that may relate to the difference in ligand-directed receptor subunit interaction. (Figs. 4 and 5) with the mOSM-specific effects on APP (Fig. 7) , namely the relative high ␣ 2 -MG and low TST or HP expression, we focused on the influence of ERK and STAT5. The effects of the two signaling pathways were assessed either by inhibiting ERK activation or by overexpressing wild type or the transdominant negative STAT5B. Treatment of mOSMR␤-expressing H-35 cells with the MEK-1 inhibitor UO126 effectively abolished activation of ERK (not shown) and suppressed induction of ␣ 2 -MG mRNA by OSM (Fig. 8A ) and protein production (Fig. 8B) . A similar, but less prominent inhibitory effect of UO126 was also observed on the action of IL-6 or LIF (or hOSM through type I OSMR) on ␣ 2 -MG expression. The same UO126-treated cells revealed a 10-fold higher HP expression after OSM treatment but only a 2-fold higher expression after IL-6 treatment. In contrast, the regulation of TST by each of the cytokine treatments was only minimally affected by UO126. These results demonstrated that cytokine-regulated ERK activity exerted a differential regulatory effect on specific APP genes. The relative ERK activation by different cytokines could, in part, contribute to the cytokinespecific APP pattern (45) .
To probe the regulatory effects of STAT5, we transfected plasmid constructs containing the promoters of the three rat APP genes fused to the CAT genes (Fig. 9A) . These constructs reproduced the cytokine-specific CAT expression in OSMR␤-H-35 cells (Fig. 9, left panel) . Elevating the concentration of wild type STAT5B by co-transfection further enhanced, by 2-fold, the mOSM-stimulated expression of the ␣ 2 -MG construct but reduced the effect on HP and TST promoters by 50% (Fig. 9, right panel) . Overexpression of the dominant-negative STAT5B⌬40C produced the opposite activity to STAT5B, lowering the OSM stimulation of ␣ 2 -MG promoter by approximately 75% and suppressing induction of TST and HP promoters in the range as noted for wild type STAT5B (Fig. 9, center  panel) . Overexpressed STAT5B proteins had only a minor influence on the inducing action of IL-6 (Fig. 9 ) that appeared proportional to the recruitment of STAT5 by IL-6 relative to OSM (Fig. 4B) .
To demonstrate that the regulation of endogenous APP genes displays similar responses to cytokine-activated STAT5 proteins as the transfected CAT reporter constructs, we analyzed mOSMR␤-H-35 cells which had been transfected with expression vectors for the wild type, or the transdominant-negative STAT5B, together with GFP and then were selected by FACS for GFP positive population (Fig. 9B) . The OSM and IL-6 stimulated production of ␣ 2 -MG and TST showed a STAT5 isoformdependent regulation that was similar to that observed for the regulation of the promoter sequences. Expression of ␣ 2 -MG was appreciably enhanced by OSM in the presence of wild type STAT5B, whereas expression of TST was reduced by both the wild type and truncated STAT5B. The relatively high amounts of STAT5 proteins achieved by the technique used in Fig. 9 , B and C, was also in part effective in modulating the effects of IL-6. Taken together, these results supported the model that mOSM-activated STAT5B, by interacting with the APRE at Ϫ200 of the ␣ 2 -MG promoter (38) , 3 could exert a positive transactivation for which the C-terminal domain of STAT5 was required. However, STAT5B also seemed to act as inhibitor of other APP genes, such as TST and HP. Conceivable modes of action could include attenuation of transcription by interaction of STAT5 with APP promoter elements or by sequesteration of other APP-promoter binding transcription factors. For either function, the presence of the C-terminal domain of STAT5 was apparently inconsequential. (Fig. 7, B and C) suggesting that LIF, in contrast to hOSM, was more effective in recruiting and coordinating the functions of LIFR␣ and gp130. A more stable LIF-dependent complex (Figs. 2 and 3 ) could be responsible for this higher sensitivity. Since separate IL-6 cytokine receptor systems co-exist in hepatic cells and that their signaling depends on a common gp130, a more effective recruitment and retention of gp130 by LIF in a LIFR complex could result in a squelching of gp130 activity. By limiting accessibility of gp130 to other IL-6 cytokine receptor subunits, LIF would determine the ability of the cells to bind other IL-6 cytokines. Thus, under conditions in which several IL-6 cytokines simultaneously interact with the cell, LIF would assume a dominant role. This influence should be particularly evident by the level of expression of those APP genes that are poorly induced by LIF. mOSMR␤-expressing H-35 cells appeared optimal for testing the hypothesis that there is a hierarchy in receptor engagement and signaling because in these cells, unlike HepG2 cells, 3 there is no shared usage of LIFR␣ and OSMR␤ by mOSM (Fig. 3A) . Treatment with dose gradients of LIF and mOSM resulted in APP expression patterns consistent with a dominant regulatory influence of LIF. One example of TST expression is shown in Fig. 10A . At low cytokine concentrations, the expression of TST was additive following addition of the two cytokines. At high LIF concentrations, the prominent action of mOSM was reduced by approximately 50%. In contrast, the low HP inducing activity of mOSM was only minimally effective in reducing the stimulation of HP expression by LIF (data not shown).
Recruitment of LIFR Is a Dominant Determinant of OSMR Action-LIF dose-response analysis indicated a higher sensitivity of H-35 cells to LIF
In agreement with the hypothesis that gp130 is sequestered by LIF-activated LIFR, induction of TST by IL-6 was also reduced by LIF (Fig. 10A) . To rule out the possibility of an inhibitory activity was specifically induced by LIF that either mediated a reduced APP induction or neutralized the signaling by other IL-6 cytokines independently from the competition for gp130, we determined the effects of LIF treatment on induction of TST in H-35 cell lines stably expressing the chimeric receptor G-CSFR-gp130 (49) . In these cells, the signaling by gp130 cytoplasmic domain was triggered by G-CSF acting independently of the endogenous gp130. These cells displayed the expected low level induction of TST by LIF in the presence of dexamethasone (Fig. 10B) . LIF reduced the action of IL-6 but not of G-CSF.
Taken together, this study documents that the IL-6 cytokines, despite their overlap in engaging common signal transduction mechanisms, have the capability through different relative ratios of signal activation to mediate cytokine-specific gene regulation. Also, in situations of multiple cytokine exposure, LIFR assumes a dominant role over the more effective signaling complex of OSMR or IL-6R.
DISCUSSION
The central issue addressed in the present study is the extent to which different members of the IL-6-type cytokines have redundant or interchangeable functions or how activities of these are specific to individual members of the family. Focusing on the OSMR, we tested the hypothesis that signal-transducing subunits of IL-6 cytokine receptors have distinct signaling capabilities and the combination of subunits establishes the specificity of cellular response to the cytokines. The following key features of the cell system used allowed us to identify signaling specificities: 1) the activities of the different receptor forms were defined in the same cellular milieu (constant gp130 content); 2) the cell response was quantifiable by the induction of several major regulated genes; and 3) the contribution of the receptor subunits to the cell response was assessed as a function of manipulated receptor expression. The results document that the representative members IL-6, LIF, and OSM elicit specific regulatory patterns and that the relative quantitative manifestation of cytokine effects is prominently influenced by the ligand-activated receptor type.
The study also led to the question of how multiple cytokines control cell function. Responsiveness of target cells to IL-6 cytokines has generally been assessed by measuring the effects of individual cytokines (25, 26, 55, 56) . However, in physiologically relevant settings, such as in the developing organism, at the site of hematopoiesis, or during immune or inflammatory reactions in vivo, a temporal and local coexistence of several members of IL-6 cytokines, as well as a plethora of other bioactive molecules, is expected (1, 14, 57, 58) . The sum of these factors will inevitably influence the function of the individual factors. This work demonstrates two such interaction: 1) LIF compared with control. B, mOSMR␤-H-35 cells in 24-well cluster plates were treated for 24 h with serially diluted cytokines (100, 10 and 1 ng/ml) in the absence or presence of dexamethasone (DEX). Aliquots of the conditioned medium were separated on 10% SDS-polyacrylamide gels. were treated for 24 h with cytokines (100 ng/ml), dexamethasone, and with or without UO126 (10 M). Total cell RNA was extracted, and aliquots of 20 g were subjected to Northern blot analysis for mRNA encoding ␣ 2 -MG, HP, and TST. B, cells were treated for 24 h with mOSM or IL-6 (100 ng/ml), dexamethasone, and increasing doses of UO126. The effect of MEK-1 inhibitor on ␣ 2 -MG, and HP was quantitatively assessed by immunoelectrophoresis. (mean Ϯ S.D.; n ϭ 3) action has dominant effects on OSM or IL-6 signaling, possibly due to the more effective recruitment of gp130 by LIFR␣ that is documented here, and 2) the action of different IL-6 cytokines is differently affected by dexamethasone.
Control of Signaling as Function of Receptor Subunit
Expression-If one assumes that gp130 is the only relevant signaltransducing subunit for all IL-6 cytokines, then a generic IL-6 cytokine profile of cell response should be detected (17) . When recording the effects of IL-6 cytokine receptors on proliferation (as exhaustedly done in the model of Ba/F3 cells), only a partial view of the signaling by IL-6 cytokines is obtained. The regulation of multiple APP genes samples a much broader array of receptor-derived signals. The results clearly demonstrate cytokine receptor-specific effects. The concept that receptor signaling is directed by modular information contained within the receptor proteins (59) leads us to propose that the composition of the oligomeric receptor subunits, recruited by the cytokines through the extracellular receptor domains, are instrumental in determining the intracellular signal specificity. The homomeric gp130 that has been predicted to be the core of the functional IL-6 receptor (60) displays structural and biochemical information by its cytoplasmic domains that is distinct from that of the heteromeric cytoplasmic domains of OSMR␤ or LIFR␣ with gp130 (19, 31-33, 60, 61) . The signal-transducing pathways recruited by OSMR␤ or LIFR␣ blend with those controlled by the common gp130.
This work suggests a highly effective contribution of OSMR␤, which exceeds that of LIFR␣ resulting in a greater activation of ERK, STAT5, and IRS pathways and, in addition, an activation of JNK (Fig. 5) . The contribution of gp130 would account in part for the qualitative similarity among IL-6 cytokine responses in the various cells types analyzed. If just the influence of receptor subunit levels is considered, the relative amount of gp130 is a major determinant of the maximal signaling capability of IL-6 cytokines in a given cell. There is no evidence for a gp130-independent signaling event elicited by either LIFR␣ or OSMR␤, although their cytoplasmic domains have signaling capabilities that have been identified in the context of chimeric receptors (29, 61, 62) . Aside from gp130, the relative amounts of IL-6R␣, LIFR␣, and/or OSMR␤ expressed at the cell surface not only determine specificity of cytokine recognition, but also influence the quantitative cell response. Limited availability of these receptor subunits will invariably result in a reduction, or absence, of a cytokine response. The extreme case represents cells with only gp130 expression, which would provide low affinity binding sites for OSM but otherwise be unable to respond to any IL-6 cytokine. However, the function of gp130 in such a cell type can still be verified by reaction with a complex of soluble IL-6R␣ with bound IL-6 that mimics an IL-6-specific recruitment and activation of the membrane resident gp130 (63, 64) .
Graded expression of transduced hOSMR␤ in Hep3B 4 and H-35 cells indicated a receptor dose-dependent inducibility of APP genes and that the relative profile of the regulated APPs was not appreciably different in cells with low versus high amounts of receptors subunits (data not presented). In our experimental system, limited amounts of OSMR␤ or LIFR␣ was not an issue; the majority of the receptor-transduced pools and clones appeared to express the receptors at a level that saturated gp130 recruitment. Similarly, further enhancement of LIFR␣ expression achieved by transduction of hLIFR␣ was unable to improve the cells response to LIF (27) . 5 Taken together these data indicate that, in reconstituted H-35 cells, the signal by IL-6, LIF, and OSM is limited by gp130 and the cell response measures maximal signaling capability by each receptor complex. The cytokine dose response (Fig. 7 , B and C) in turn illustrates the signaling efficiency. We assume that any excess amounts of LIFR␣ or OSMR␤ expressed by H-35 cells are inconsequential as far as signaling is concerned. However, excess subunits could enhance low affinity cytokine binding activity of the cells (19, 32) .
Receptor Subunits Define Signaling Specificity-The marked difference in APP gene regulation and suppressed proliferation by OSM and LIF, compared with IL-6, is attributed to signaling by the cytoplasmic domains of OSMR␤ and LIFR␣. Although the primary structures of mouse and human OSMR␤ show 45% sequence difference, both have comparable signaling effects when the contribution of co-activated LIFR␣-gp130 by hOSM is discounted (Fig. 4) . The cytoplasmic domains of human and mouse of OSMR␤ contain the same structural motifs associated with signal communication, e.g. JAK and STAT3 (32, 33) . Both subunits are devoid of a SHP-2 docking element, thus explaining the failure to co-immunoprecipitate OSMR␤ with SHP-2 (Fig. 6A) . The recovery of SHC with OSMR␤ suggested that this adaptor protein may contribute to the prominent MAPK recruitment by OSMR complex (46) . 2 The coactivated gp130 may be responsible for recruitment and phosphorylation of SHP-2 (28, 35, 49) . A single SHP-2-binding site per OSMR complex, as opposed to two in the IL-6R complex, could also reduce the probability of the receptor complex (including their associated kinases) being dephosphorylated and thereby deactivated by receptor-recruited SHP-2 (35) . Although in other cell types SHC has been described in association with IL-6-induced gp130 signaling (65, 66) , its relative contribution in the hepatoma cells to the IL-6 response appears minor (49) . Recovery of LIFR␣ as part of the ligand-activated LIFR co-immunoprecipitated with anti-SHP-2 is probably due to gp130 that is tightly associated with LIFR␣. LIFR␣ does not contain an effective SHP-2 docking site in its cytoplasmic domain, although one at tyrosine 115 has been suggested (67) . LIFR␣ cannot be recovered as SHP-2-associated protein when activated by OSM suggesting a lower affinity interaction with gp130. Similarly, no SHP-2 association with the cytoplasmic domain of OSMR␤ or LIFR␣ could be detected when these were part of G-CSF-activated, homomeric G-CSFR-chimeras. 4, 5 Inasmuch as the precise signal transduced from OSMR␤ and LIFR␣ toward the MAPK/ERK pathway and the basis for the kinetic differences in activation remain to be established (68, 69) , it is evident (Fig. 4) that both receptor subunits assist in a more active process than the IL-6-stimulated gp130 dimer. Furthermore, the subunits, in particular OSMR␤, promote a more effective STAT5 recruitment (Fig. 4, B and C; Ref. 50 ). Preliminary characterization of mutations in the 6 tyrosine residues conserved between human and mouse OSMR␤ could not assign a STAT5-specific docking and activation site. 4 An alternative model proposes that JAKs could be responsible for direct STAT5 activation (70) as well as for the engagement of IRS (50) . Both the prominent ERK and STAT5 activation by OSM has been associated with modulated APP gene expression in H-35 cells (Fig. 8) and primary cultures of mouse and rat hepatocytes (data not presented). OSMR signaling matches the effect of growth hormone receptor on STAT5 recruitment in liver cells (71) . However, in contrast to growth hormone, OSM may contribute to the nuclear accumulation of STAT5 in liver cells during an adjuvant-induced inflammatory response (38) . It remains to be determined whether STAT5 is also responsible for the particularly abundant hepatic expression of ␣ 2 -MG during an inflammatory reaction in rats (39, 72) .
Cross-modulation between IL-6 Cytokine Family Receptors as a Mechanism Controlling Cytokine Responsiveness in Cells-
LIFR is expressed in many cell types and seems particularly relevant, among others, in directing neuronal regeneration (73, 74) , control of the hypothalamic-adrenal axis (75) , stress response of myocardiocytes (76) , embryonal implantation (77) , and differentiation of the renal mesenchyme to an epithelial structure (78) . Surprisingly, the mode of LIFR␣ action is still largely unknown. In regards to liver cell regulation, the molecular biology behind the relative low level of LIFR-directed induction of several APPs is similarly unexplained. A relevant finding is that cells respond more sensitively to LIF than to IL-6 and OSM. The same subunits as part of hOSM-activated type I OSMR do not generate a sensitivity as great as that seen with the LIF-activated complex (Fig. 7B) . The difference may be due to the more stable receptor complex recruitment by LIF. An efficient interaction among the components of the LIFR complex is suggested by the binding of LIF to LIFR␣ through two interaction sites that involve a coordination of LIF with the first hematopoietin domain and the immunoglobin domain of LIFR␣ (79, 80) . The immunoglobulin domain is not involved in OSM binding (80) , potentially explaining the lower affinity association of type I OSMR subunits. A critical consequence of the effective interaction of LIF and LIFR on signaling functions is that LIFR action appears dominant over the more active OSMR or IL-6R complexes (Fig. 10) . In fact, a similar modulating activity of LIF on OSM-stimulated APP expression had been noted in earlier studies in HepG2 cells, but left unexplained (26) .
The ability of LIFR to influence the cells to respond to other IL-6 cytokines is potentially critical where OSM, IL-6, and LIF are simultaneously presented to cells that express the appropriate receptors. Moreover, specific activities of the different IL-6 class cytokines are probably not restricted to hepatic cells, but also occur in other cell types such as fibroblasts and mesenchymal cells that have highly effective LIFR and OSMR systems. Hence, the cells response to multiple IL-6 cytokines may be distinct from the one predicted when just considering the effects of individual cytokines. It is reasonable to assume that the mode of regulation by the interplay of the receptors has physiological relevance. Thus, the pharmacological intervention by administrating specific IL-6 cytokines, or the soluble IL-6R␣⅐IL-6 complex, including the particularly effective hyper-IL-6 (81), could produce a type of cell regulation, such as an excessive IL-6-like response, that may differ from what is desired for optimal benefit (82, 83) .
This study has revealed new avenues for directing IL-6 cytokine regulation in cells. The recruitment of distinct signaltransducing pathways by the cytoplasmic receptor domains appears to play an important role in determining the initiation of signaling. However, many physiological processes, such as APP induction in hepatic cells, regulated proliferation in lymphoid cells, or the differentiation program in mesenchymal cells, depend on long term treatment that could last for days. Aside from competition for gp130 recruitment, cross-modulation of IL-6 receptor systems may involve other effective pathways such as changes in the available amounts of receptor subunits, signaling proteins, or transcription factors. Understanding of these mechanisms is crucial in predicting the physiological role of IL-6 cytokines.
